Aberrant DNA Methylation in Thymic Epithelial Tumors

REFERENCES

• Masaoka A., Monden Y., Nakahara K., Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981; 48: 2485–2492
   PubMed Web of Science ®Google Scholar
• Shimosato Y. Controversies surrounding the subclassification of thymoma. Cancer 1994; 74: 542–544
   PubMed Web of Science ®Google Scholar
• Quintanilla Martinez L., Wilkins E. W., Jr, Choi N., Efird J., Hug E., Harris N. L. Thymoma. Histologic subclassification is an independent prognostic factor. Cancer 1994; 74: 606–617
   Google Scholar
• Lardinois D., Rechsteiner R., Lang R. H., Gugger M., Betticher D., von Briel C., Krueger T., Ris H. B. Prognostic relevance of Masaoka and Muller-Hermelink classification in patients with thymic tumors. Ann Thorac Surg 2000; 69: 1550–1555
   PubMed Web of Science ®Google Scholar
• Rosai J., Sobin L. H. Histological typing of tumors of the thymus. International Histological Classification of Tumors 2nd. Springer, New YorkBerlin 1999
   Google Scholar
• Nakagawa K., Asamura H., Matsuno Y., Suzuki K., Kondo H., Maeshima A., Miyaoka E., Tsuchiya R. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 2003; 126: 1134–1140
   PubMed Web of Science ®Google Scholar
• Chen G., Marx A., Wen-Hu C., Yong J., Puppe B., Stroebel P., Mueller-Hermelink H. K. New WHO histological classification predicts prognosis of thymic epithelial tumors. A clinicopathologic study of 200 thymoma cases from China. Cancer 2002; 95: 420–429
   Google Scholar
• Ströbel P., Bauer A., Puppe B., Kraushaar T., Krein A., Toyka K., Gold R., Semik M., Kiefer R., Nix W., Schalke B., Müller-Hermelink H. K., Marx A. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol 2004; 22: 1501–1509
   PubMed Web of Science ®Google Scholar
• Wentao F., Wenhu C., Gang C., Yong J. Surgical management of thymic epithelial tumors: a retrospective review of 204 cases. Ann Thorac Surg 2005; 80: 2002–2007
   PubMed Web of Science ®Google Scholar
• Zisis C., Rontogianni D., Tzavara C., Stefanaki K., Chatzimichalis A., Loutsidis A., Iliadis K., Kontaxis A., Dosios T., Bellenis I. Prognostic factors in thymic epithelial tumors undergoing complete resection. Ann Thorac Surg 2005; 80: 1056–1062
   PubMed Web of Science ®Google Scholar
• Rountree M. R., Bachman K. E., Herman J. G., Baylin S. B. DNA methylation, chromatin inheritance, and cancer. Oncogene 2001; 20: 3156–3165
   PubMed Web of Science ®Google Scholar
• Matsuzaki K., Deng G., Tanaka H., Kakar S., Miura S., Kim Y. S. The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer. Clin Cancer Res 2005; 8564–8569
   PubMed Web of Science ®Google Scholar
• Eden A., Gaudet F., Waghmare A., Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003; 300: 455
   PubMed Web of Science ®Google Scholar
• Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 2002; 21: 5400–5413
   PubMed Web of Science ®Google Scholar
• Tuck-Muller C. M., Narayan A., Tsien F., Smeets D. F., Sawyer J., Fiala E. S., Sohn O. S., Ehrlich M. DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients. Cytogenet Cell Genet 2000; 89: 121–128
   PubMedGoogle Scholar
• Deng G., Nguyen A., Tanaka H., Matsuzaki K., Bell I., Mehta K. R., Terdiman J. P.; Waldman, F.M.; Kakar, S.; Gum, J.; Crawley, S.; Sleisenger, M.H.; Kim, Y.S. Regional hypermethylation and global hypomethylation are associated with altered chromatin conformation and histone acetylation in colorectal cancer. Int J Cancer 2006; 118: 2999–3005
   Google Scholar
• Kondo Y., Issa J. P. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev 2004; 23: 29–39
   PubMed Web of Science ®Google Scholar
• Tomizawa Y., Iijima H., Nomoto T., Iwasaki Y., Otani Y., Tsuchiya S., Saito R., Dobashi K., Nakajima T., Mori M. Clinicopathological significance of aberrant methylation of RARβ 2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer. Lung Cancer 2004; 46(3)305–312
   PubMed Web of Science ®Google Scholar
• Kim D. S., Kim M. J., Lee J. Y., Kim Y. Z., Kim E. J., Park J. Y. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features. Cancer 2007; 110(12)2785–2792
   PubMed Web of Science ®Google Scholar
• Fischer J. R., Ohnmacht U., Rieger N., Zemaitis M., Stoffregen C., Manegold C., Lahm H. Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine. Lung Cancer 2007; 56(1)115–123
   PubMed Web of Science ®Google Scholar
• Corn P. G., Heath E. I., Heitmiller R., Fogt F., Forastiere A. A., Herman J. G., Wu T. T. Frequent Hypermethylation of the 5-CpG Island of E-Cadherin in Esophageal Adenocarcinoma. Clin Cancer Res 2001; 7: 2765–2769
   PubMed Web of Science ®Google Scholar
• van Engeland M., Weijenberg M. P., Roemen G. M., Brink M., de Bruine A. P., Goldbohm R. A., van den Brandt P. A., Baylin S. B., de Goeij A. F., Herman J. G. Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. Cancer Res 2003; 63(12)3133–3137
   PubMed Web of Science ®Google Scholar
• Girault I., Tozlu S., Lidereau R., Bieche I. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Clin Cancer Res 2003; 9(12)4415–4422
   PubMed Web of Science ®Google Scholar
• Shieh Y. S., Shiah S. G., Jeng H. H., Lee H. S., Wu C. W., Chang L. C. DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma. Cancer 2005; 104(5)1013–1021
   PubMed Web of Science ®Google Scholar
• Zettl A., Strobel P., Wagner K., Katzenberger T., Ott G., Rosenwald A., Peters K., Krein A., Semik M., Müller-Hermelink H. K., Marx A. Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol 2000; 157: 257–266
   PubMed Web of Science ®Google Scholar
• Hirabayashi H., Fujii Y., Sakaguchi M., Tanaka H., Yoon H. E., Komoto Y., Inoue M., Miyoshi S., Matsuda H. p16INK4a, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma. Int J Cancer 1997; 73(5)639–644
   PubMed Web of Science ®Google Scholar
• Long C., Yin B., Lu Q., Zhou X., Hu J., Yang Y., Yu F., Yuan Y. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma. Cancer Invest 2007; 25(8)685–690
   PubMed Web of Science ®Google Scholar
• Hernandez-Blazquez F. J., Habib M., Dumollard J. M., Barthelemy C., Benchaib M., de Capoa A., Niveleau A. Evaluation of global DNA hypomethylation in human colon cancer tissues by immunohistochemistry and image analysis. Gut 2000; 47(5)689–693
   PubMed Web of Science ®Google Scholar
• Esteller M., Herman J. G. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumors. J Pathol 2002; 196: 1–7
   PubMed Web of Science ®Google Scholar
• Wilson A. S., Power B. E., Molloy P. L. DNA hypomethylation and human diseases. Biochim Biophys Acta 2007; 1775(1)138–162
   PubMed Web of Science ®Google Scholar
• de Capoa A., Musolino A., Della Rosa S., Caiafa P., Mariani L., Del Nonno F., Vocaturo A., Donnorso R. P., Niveleau A., Grappelli C. DNA demethylation is directly related to tumour progression: evidence in normal, pre-malignant and malignant cells from uterine cervix samples. Oncol Rep 2003; 10(3)545–549
   PubMed Web of Science ®Google Scholar
• Piyathilake C. J., Frost A. R., Bell W. C., Oelschlager D., Weiss H., Johanning G. L., Niveleau A., Heimburger D. C., Grizzle W. E. Altered global methylation of DNA: an epigenetic difference in susceptibility for lung cancer is associated with its progression. Hum Pathol 2001; 32(8)856–862
   PubMed Web of Science ®Google Scholar
• Piyathilake C. J., Henao O., Frost A. R., Macaluso M., Bell W. C., Johanning G. L., Heimburger D. C., Niveleau A., Grizzle W. E. Race- and age-dependent alterations in global methylation of DNA in squamous cell carcinoma of the lung (United States). Cancer Causes Control 2003; 14(1)37–42
   PubMed Web of Science ®Google Scholar
• Seifert H. H., Schmiemann V., Mueller M., Kazimirek M., Onofre F., Neuhausen A., Florl A. R., Ackermann R., Boecking A., Schulz W. A., Grote H. J. In situ detection of global DNA hypomethylation in exfoliative urine cytology of patients with suspected bladder cancer. Exp Mol Pathol 2007; 82(3)292–297
   PubMed Web of Science ®Google Scholar
• Brothman A. R., Swanson G., Maxwell T. M., Cui J., Murphy K., Herrick J., Speights V., Isaac J., Rohr L. Global hypomethylation is common in prostate cancer cells: a quantitative predictor for clinical outcome?. Cancer Genet Cytogenet 2005; 156(1)31–36
   PubMed Web of Science ®Google Scholar
• Yang X., Phillips D. L., Ferguson A. T., Nelson W. G., Herman J. G., Davidson N. E. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. Cancer Res 2001; 61(19)7025–7029
   PubMed Web of Science ®Google Scholar